Stay updated on PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial

Sign up to get notified when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now presents the completed Phase 1 study comparing PF-06438179 with U.S. and EU infliximab in healthy volunteers, including its design, eligibility criteria, study location, and measured outcomes.
    Difference
    42%
    Check dated 2026-11-08T12:48:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T13:24:51.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:11:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:21.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:06:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content and navigation. This indicates access to the record is restricted.
    Difference
    17%
    Check dated 2026-09-20T19:41:44.000Z thumbnail image

Stay in the know with updates to PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.